Dietary fat intake and risk of Parkinson's disease: A case-control study in Japan

Journal of the Neurological Sciences

Volumn 288, Issue 1-2, 2010, Pages 117-122

  Miyake, Yoshihiro ^a   Sasaki, Satoshi ^b   Tanaka, Keiko ^a   Fukushima, Wakaba ^c   Kiyohara, Chikako ^d   Tsuboi, Yoshio ^a   Yamada, Tatsuo ^a   Oeda, Tomoko ^e   Miki, Takami ^c   Kawamura, Nobutoshi ^d   Sakae, Nobutaka ^d   Fukuyama, Hidenao ^f   Hirota, Yoshio ^c   Nagai, Masaki ^g  

^a FUKUOKA UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d KYUSHU UNIVERSITY   (Japan)

^e UTANO NATIONAL HOSPITAL   (Japan)

^f KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^g SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Arachidonic acid; Case control studies; Cholesterol; Diet; Fatty acids; Japan; Parkinson disease

Indexed keywords

ARACHIDONIC ACID; DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; LINOLEIC ACID; MONOUNSATURATED FATTY ACID; OMEGA 3 FATTY ACID;

ADULT; AGED; ARTICLE; CHOLESTEROL INTAKE; CONTROLLED STUDY; DEGENERATIVE DISEASE; FAT INTAKE; FEMALE; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; PARKINSON DISEASE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK FACTOR;

AGED; CASE-CONTROL STUDIES; CHOLESTEROL, DIETARY; DIET SURVEYS; DIETARY FATS; FATTY ACIDS; FATTY ACIDS, OMEGA-3; FEMALE; FOOD HABITS; HUMANS; JAPAN; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PARKINSON DISEASE; QUESTIONNAIRES; SOCIOECONOMIC FACTORS;

EID: 70949097459     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2009.09.021     Document Type: Article

References (43)

1. Morioka S., Sakata K., Yoshida S., Nakai E., Shiba M., Yoshimura N., et al. Incidence of Parkinson disease in Wakayama, Japan. J Epidemiol 12 (2002) 403-407
2. Jenner P. Oxidative stress in Parkinson's disease. Ann Neurol 53 (2003) S26-S36 Suppl
3. Wüllner U., and Klockgether T. Inflammation in Parkinson's disease. J Neurol 250 (2003) I35-I38 Suppl
4. Schapira A.H. Mitochondrial dysfunction in Parkinson's disease. Cell Death Differ 14 (2007) 1261-1266
5. Hashimoto M., Hossain S., Shimada T., Sugioka K., Yamasaki H., Fujii Y., et al. Docosahexaenoic acid provides protection from impairment of learning ability in Alzheimer's disease model rats. J Neurochem 81 (2002) 1084-1091
6. Wu A., Ying Z., and Gomez-Pinilla F. Dietary omega-3 fatty acids normalize BDNF levels, reduce oxidative damage, and counteract learning disability after traumatic brain injury in rats. J Neurotrauma 21 (2004) 1457-1467
7. Hashimoto M., Tanabe Y., Fujii Y., Kikuta T., Shibata H., and Shido O. Chronic administration of docosahexaenoic acid ameliorates the impairment of spatial cognition learning ability in amyloid beta-infused rats. J Nutr 135 (2005) 549-555
8. De Smedt-Peyrusse V., Sargueil F., Moranis A., Harizi H., Mongrand S., and Layé S. Docosahexaenoic acid prevents lipopolysaccharide-induced cytokine production in microglial cells by inhibiting lipopolysaccharide receptor presentation but not its membrane subdomain localization. J Neurochem 105 (2008) 296-307
9. Calon F., Lim G.P., Yang F., Morihara T., Teter B., Ubeda O., et al. Docosahexaenoic acid protects from dendritic pathology in an Alzheimer's disease mouse model. Neuron 43 (2004) 633-645
10. Jump D.B. Dietary polyunsaturated fatty acids and regulation of gene transcription. Curr Opin Lipidol 13 (2002) 155-164
11. Akbar M., and Kim H.Y. Protective effects of docosahexaenoic acid in staurosporine-induced apoptosis: involvement of phosphatidylinositol-3 kinase pathway. J Neurochem 82 (2002) 655-665
12. Akbar M., Calderon F., Wen Z., and Kim H.Y. Docosahexaenoic acid: a positive modulator of Akt signaling in neuronal survival. Proc Natl Acad Sci U S A. 102 (2005) 10858-10863
13. Calon F., Lim G.P., Morihara T., Yang F., Ubeda O., Salem Jr. N., et al. Dietary n-3 polyunsaturated fatty acid depletion activates caspases and decreases NMDA receptors in the brain of a transgenic mouse model of Alzheimer's disease. Eur J Neurosci 22 (2005) 617-626
14. Kim H.Y. Novel metabolism of docosahexaenoic acid in neural cells. J Biol Chem 282 (2007) 18661-18665
15. Montine K.S., Quinn J.F., Zhang J., Fessel J.P., Roberts II L.J., Morrow J.D., et al. Isoprostanes and related products of lipid peroxidation in neurodegenerative diseases. Chem Phys Lipids 128 (2004) 117-124
16. Levant B., Ozias M.K., and Carlson S.E. Specific brain regions of female rats are differentially depleted of docosahexaenoic acid by reproductive activity and an (n-3) fatty acid-deficient diet. J Nutr 137 (2007) 130-134
17. Bowen R.A., and Clandinin M.T. Dietary low linolenic acid compared with docosahexaenoic acid alter synaptic plasma membrane phospholipid fatty acid composition and sodium-potassium ATPase kinetics in developing rats. J Neurochem 83 (2002) 764-774
18. Ikemoto A., Ohishi M., Sato Y., Hata N., Misawa Y., Fujii Y., et al. Reversibility of n-3 fatty acid deficiency-induced alterations of learning behavior in the rat: level of n-6 fatty acids as another critical factor. J Lipid Res 42 (2001) 1655-1663
19. Tan L.C., Koh W.P., Yuan J.M., Wang R., Au W.L., Tan J.H., et al. Differential effects of black versus green tea on risk of Parkinson's disease in the Singapore Chinese Health study. Am J Epidemiol 167 (2008) 553-560
20. Chen H., O'Reilly E., McCullough M.L., Rodriguez C., Schwarzschild M.A., Calle E.E., et al. Consumption of dairy products and risk of Parkinson's disease. Am J Epidemiol 165 (2007) 998-1006
21. de Lau L.M., Bornebroek M., Witteman J.C., Hofman A., Koudstaal P.J., and Breteler M.M. Dietary fatty acids and the risk of Parkinson disease: the Rotterdam study. Neurology 64 (2005) 2040-2045
22. Chen H., Zhang S.M., Hernán M.A., Willett W.C., and Ascherio A. Dietary intakes of fat and risk of Parkinson's disease. Am J Epidemiol 157 (2003) 1007-1014
23. Powers K.M., Smith-Weller T., Franklin G.M., Longstreth Jr. W.T., Swanson P.D., and Checkoway H. Parkinson's disease risks associated with dietary iron, manganese, and other nutrient intakes. Neurology 60 (2003) 1761-1766
24. Johnson C.C., Gorell J.M., Rybicki B.A., Sanders K., and Peterson E.L. Adult nutrient intake as a risk factor for Parkinson's disease. Int J Epidemiol 28 (1999) 1102-1109
25. Anderson C., Checkoway H., Franklin G.M., Beresford S., Smith-Weller T., and Swanson P.D. Dietary factors in Parkinson's disease: the role of food groups and specific foods. Mov Disord 14 (1999) 21-27
26. Logroscino G., Marder K., Cote L., Tang M.X., Shea S., and Mayeux R. Dietary lipids and antioxidants in Parkinson's disease: a population-based, case-control study. Ann Neurol 39 (1996) 89-94
27. Hellenbrand W., Boeing H., Robra B.P., Seidler A., Vieregge P., Nischan P., et al. Diet and Parkinson's disease. II: A possible role for the past intake of specific nutrients. Results from a self-administered food-frequency questionnaire in a case-control study. Neurology 47 (1996) 644-650
28. Morens D.M., Grandinetti A., Waslien C.I., Park C.B., Ross G.W., and White L.R. Case-control study of idiopathic Parkinson's disease and dietary vitamin E intake. Neurology 46 (1996) 1270-1274
29. Hughes A.J., Daniel S.E., Kilford L., and Lees A.J. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55 (1992) 181-184
30. Sasaki S., Yanagibori R., and Amano K. Self-administered diet history questionnaire developed for health education: a relative validation of the test-version by comparison with 3-day diet record in women. J Epidemiol 8 (1998) 203-215
31. Sasaki S., Ushio F., Amano K., Morihara M., Todoriki T., Uehara Y., et al. Serum biomarker-based validation of a self-administered diet history questionnaire for Japanese subjects. J Nutr Sci Vitaminol 46 (2000) 285-296
32. Science and Technology Agency. Standard tables of food composition in Japan. 5th revised and enlarged ed (2005), Printing Bureau of the Ministry of Finance, Tokyo, Japan in Japanese
33. Science and Technology Agency. Standard Tables of Food Composition in Japan, fatty acids section. 5th revised and enlarged ed (2005), Printing Bureau of the Ministry of Finance, Tokyo, Japan in Japanese
34. Willett W., and Stampfer M.J. Total energy intake: implications for epidemiologic analyses. Am J Epidemiol 124 (1986) 17-27
35. Fessel J.P., Hulette C., Powell S., Roberts II L.J., and Zhang J. Isofurans, but not F2-isoprostanes, are increased in the substantia nigra of patients with Parkinson's disease and with dementia with Lewy body disease. J Neurochem 85 (2003) 645-650
36. Rosenberger T.A., Villacreses N.E., Hovda J.T., Bosetti F., Weerasinghe G., Wine R.N., et al. Rat brain arachidonic acid metabolism is increased by a 6-day intracerebral ventricular infusion of bacterial lipopolysaccharide. J Neurochem 88 (2004) 1168-1178
37. Hu G., Antikainen R., Jousilahti P., Kivipelto M., and Tuomilehto J. Total cholesterol and the risk of Parkinson disease. Neurology 70 (2008) 1972-1979
38. de Lau L.M., Koudstaal P.J., Hofman A., and Breteler M.M. Serum cholesterol levels and the risk of Parkinson's disease. Am J Epidemiol 164 (2006) 998-1002
39. Simon K.C., Chen H., Schwarzschild M., and Ascherio A. Hypertension, hypercholesterolemia, diabetes, and risk of Parkinson disease. Neurology 69 (2007) 1688-1695
40. Huang X., Abbott R.D., Petrovitch H., Mailman R.B., and Ross G.W. Low LDL cholesterol and increased risk of Parkinson's disease: prospective results from Honolulu-Asia Aging Study. Mov Disord 23 (2008) 1013-1018
41. Wang G.J., Volkow N.D., and Fowler J.S. The role of dopamine in motivation for food in humans: implications for obesity. Expert Opin Ther Targets 6 (2002) 601-609
42. Abbott R.D., Petrovitch H., White L.R., Masaki K.H., Tanner C.M., Curb J.D., et al. Frequency of bowel movements and the future risk of Parkinson's disease. Neurology 57 (2001) 456-462
43. Ponsen M.M., Stoffers D., Booij J., van Eck-Smit B.L., Wolters E.Ch., and Berendse H.W. Idiopathic hyposmia as a preclinical sign of Parkinson's disease. Ann Neurol 56 (2004) 173-181